Seattle biotech startup Tune Therapeutics lands $175M to support clinical research Tune Therapeutics, a biotech company with headquarters in Seattle and Durham, N.C., raised $175 million in one of the largest… Read More
Paul G. Allen Frontiers Group gives $7.5M to studies on epigenetics, aging, evolution Epigenetics, aging and microbial evolution: Those are the latest words in biomedical research for the Paul G. Allen Frontiers Group,… Read More
Fred Hutch researchers discover way to re-activate ‘silenced’ genes, in possible treatment for Rett Syndrome and other diseases Rett Syndrome is not a common disorder, but it is a devastating one. It is a neurological developmental disorder and is… Read More
